The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes
Open accessAbstract
BACKGROUND: The "complex of myxomas, spotty skin pigmentation, and endocrine overactivity," or "Carney complex" (CNC), is caused by inactivating mutations of the regulatory subunit type 1A of the cAMP-dependent protein kinase (PRKAR1A) gene and as yet unknown defect(s) in other gene(s). Delineation of a genotype-phenotype correlation for CNC patients is essential for understanding PRKAR1A function and providing counseling and preventive care. METHODS: A transatlantic consortium studied the molecular genotype and clinical phenotype of 353 patients (221 females and 132 males, age 34 +/- 19 yr) who carried a germline PRKAR1A mutation or were diagnosed with CNC and/or primary pigmented nodular adrenocortical disease. RESULTS: A total of 258 patients (73%) carried 80 different PRKAR1A mutations; 114 (62%) of the index cases had a PRKAR1A mutation. Most PRKAR1A mutations (82%) led to lack of detectable mutant protein (nonexpressed mutations) because of nonsense mRNA mediated decay. Patients with a PRKAR1A mutation were more likely to have pigmented skin lesions, myxomas, and thyroid and gonadal tumors; they also presented earlier with these tumors. Primary pigmented nodular adrenocortical disease occurred earlier, was more frequent in females, and was the only manifestation of CNC with a gender predilection. Mutations located in exons were more often associated with acromegaly, myxomas, lentigines, and schwannomas, whereas the frequent c.491-492delTG mutation was commonly associated with lentigines, cardiac myxomas, and thyroid tumors. Overall, nonexpressed PRKAR1A mutations were associated with less severe disease. CONCLUSION: CNC is genetically and clinically heterogeneous. Certain tumors are more frequent, with specific mutations providing some genotype-phenotype correlation for PRKAR1A mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945
Self-citation
Research works printed but not linked: 37
- Michels, 1986, A new inherited syndrome with cardiac, cutaneous, and endocrine involvement., Mayo Clin Proc, 61, 224, 10.1016/S0025-6196(12)61854-0 · DOI
- Carney, 1985, The complex of myxomas, spotty pigmentation, and endocrine overactivity., Medicine (Baltimore), 64, 270, 10.1097/00005792-198507000-00007 · DOI · Paper page
- Boikos, 2007, Carney complex: the first 20 years., Curr Opin Oncol, 19, 24, 10.1097/CCO.0b013e32801195eb · DOI · Paper page
- Carney, 1995, Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas., Semin Dermatol, 14, 90, 10.1016/S1085-5629(05)80003-3 · DOI · Paper page
- Stratakis, 1996, Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2., J Clin Invest, 97, 699, 10.1172/JCI118467 · DOI · Paper page
- OMIM no. 160980. http://www.ncbi.nlm.nih.gov/omim/
- Conroy, 2004, Atrial myxoma: a cardiocutaneous syndrome., Hosp Med, 65, 56, 10.12968/hosp.2004.65.1.2423 · doi:10.12968/hosp.2004.65.1.2423
- Kojima, 2005, A Japanese case of familial cardiac myxoma associated with a mutation of the PRKAR1α gene., Intern Med, 44, 607, 10.2169/internalmedicine.44.607 · DOI
- Skamrov, 2003, [PRKAR1A gene mutations in two patients with myxoma syndrome (Carney complex)]., Kardiologiia, 43, 77
- Wieacker, 2007, Male infertility as a component of Carney complex., Andrologia, 39, 196, 10.1111/j.1439-0272.2007.00784.x · DOI
- Yoon, 2003, A typical Korean case of Carney complex., Korean J Intern Med, 18, 260, 10.3904/kjim.2003.18.4.260 · doi:10.3904/kjim.2003.18.4.260
- Kirschner, 2000, Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex., Hum Mol Genet, 9, 3037, 10.1093/hmg/9.20.3037 · DOI · Paper page
- Stratakis, 2001, Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation., J Clin Endocrinol Metab, 86, 4041, 10.1210/jcem.86.9.7903 · doi:10.1210/jcem.86.9.7903 · Paper page
- Robinson-White, 2003, Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2., Hum Mol Genet, 12, 1475, 10.1093/hmg/ddg160 · DOI
- Groussin, 2002, Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD., Am J Hum Genet, 71, 1433, 10.1086/344579 · DOI · Paper page
- Nadella, 2005, Disruption of protein kinase A regulation causes immortalization and dysregulation of D-type cyclins., Cancer Res, 65, 10307, 10.1158/0008-5472.CAN-05-3183 · DOI
- Robinson-White, 2006, PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes., Cancer Res, 66, 10603, 10.1158/0008-5472.CAN-06-2200 · DOI
- Horvath, 2008, Large deletions of the PRKAR1A gene in Carney complex., Clin Cancer Res, 14, 388, 10.1158/1078-0432.CCR-07-1155 · DOI
- Groussin, 2006, A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds., J Clin Endocrinol Metab, 91, 1943, 10.1210/jc.2005-2708 · DOI
- Greene, 2008, In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay., Hum Mut, 29, 633, 10.1002/humu.20688 · DOI
- Malchoff, 2000, Editorial: Carney complex–clarity and complexity., J Clin Endocrinol Metab, 85, 4010
- Nesterova, 2006, Autoantibody cancer biomarker: extracellular protein kinase A., Cancer Res, 66, 8971, 10.1158/0008-5472.CAN-06-1049 · DOI
- Horvath, 2006, A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia., Nat Genet, 38, 794, 10.1038/ng1809 · DOI · Paper page
- Horvath, 2006, Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population., Cancer Res, 66, 11571, 10.1158/0008-5472.CAN-06-2914 · DOI
- Horvath, 2008, Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia., N Engl J Med, 358, 750, 10.1056/NEJMc0706182 · DOI · Paper page
- Meoli, 2008, Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors., Cancer Res, 68, 3133, 10.1158/0008-5472.CAN-08-0064 · DOI
- Veugelers, 2004, Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice., Proc Natl Acad Sci USA, 101, 14222, 10.1073/pnas.0405535101 · DOI
- Mavrakis, 2006, Depletion of type IA regulatory subunit (RIα) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency., Hum Mol Genet, 15, 2962, 10.1093/hmg/ddl239 · DOI
- Liu, 2003, Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues., FASEB J, 17, 1189, 10.1096/fj.02-1066fje · DOI
- Matyakhina, 2003, Chromosome 2 (2p16) abnormalities in Carney complex tumours., J Med Genet, 40, 268, 10.1136/jmg.40.4.268 · DOI
- Rosenberg, 2002, cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors., Endocr Res, 28, 765, 10.1081/ERC-120017071 · DOI
- Cazabat, 2006, PRKAR1A mutations in primary pigmented nodular adrenocortical disease., Pituitary, 9, 211, 10.1007/s11102-006-0266-1 · DOI
- Stratakis, 2007, Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: the NIH studies., Horm Metab Res, 39, 467, 10.1055/s-2007-981477 · DOI
- Amieux, 2002, The essential role of RI α in the maintenance of regulated PKA activity., Ann NY Acad Sci, 968, 75, 10.1111/j.1749-6632.2002.tb04328.x · DOI · Paper page
- Griffin, 2004, Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors., Cancer Res, 64, 8811, 10.1158/0008-5472.CAN-04-3620 · DOI
- Kirschner, 2005, A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues., Cancer Res, 65, 4506, 10.1158/0008-5472.CAN-05-0580 · DOI · Paper page
- Griffin, 2004, A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions., J Med Genet, 41, 923, 10.1136/jmg.2004.028043 · DOI
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Beckers, A., Aaltonen, L. A., Daly, A. F., & Karhu, A. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1013 · Cited by 360
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“An example of this is constitutive activation of adenylyl cyclase as a result of somatic GNAS mutations in McCune– Albright syndrome (144).”
BackgroundRipperger, T., Bielack, S. S., Borkhardt, A., Brecht, I. B., Burkhardt, B., Calaminus, G., Debatin, K., Deubzer, H., Dirksen, U., Eckert, C., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38142 · Cited by 283
Metadata
- Authors
- Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., René-Corail, F., Stergiopoulos, S., Bourdeau, I., Bei, T., Clauser, E., Calender, A., Kirschner, L. S., Bertagna, X., Carney, J. A., & Stratakis, C. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-06-01
- Volume
- 94
- Issue
- 6
- Pages
- 2085-2091
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2095849867
- Cited by
- 449
- References
- 2
- FWCI
- 24.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes. https://app.cochat.ai/papers/10.1210/jc.2008-2333
- The paper
- Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., René-Corail, F., Stergiopoulos, S., Bourdeau, I., Bei, T., Clauser, E., Calender, A., Kirschner, L. S., Bertagna, X., Carney, J. A., & Stratakis, C. A. (2009). Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-2333
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.